Advertisement
  • Reuters

    CVS cuts 2024 profit forecast as soaring medical costs hit insurance unit

    The U.S. healthcare giant cut its per-share adjusted earnings forecast for 2024 to at least $7.00 from at least $8.30, adding it anticipates the surge in medical procedures at its unit that houses health insurer Aetna to persist. U.S. health insurers have had to contend with rising medical costs over the past few quarters following higher demand for procedures, especially among older adults, that were delayed during the pandemic. CVS in February reported an increase in costs in its Aetna Medicare Advantage plans for the fourth quarter, citing a rise in hip and knee surgeries, medical services related to the eyes, dental work and vaccinations including the RSV shot.

  • Thomson Reuters StreetEvents

    Q1 2024 Silk Road Medical Inc Earnings Call

    Q1 2024 Silk Road Medical Inc Earnings Call

  • Reuters

    Apple set for big sales decline as investors await AI in iPhones

    Apple's plan to add generative AI to its iPhones and revive sagging sales in the crucial Chinese market will be in focus on Thursday, when the tech giant is expected to report its biggest quarterly revenue decline in more than a year. Long considered a must-own stock on Wall Street, Apple shares have underperformed other Big Tech companies in recent months, falling more than 10% year to date as fears mount about its slow roll out of AI services and as a resurgent Huawei takes market share in China. Analysts on average see iPhone sales, which account for about half of Apple's revenue, falling 10.4% in the first three months of 2024, according to LSEG.